Furthermore, hyperoside enhances the sensitivity of cancer cells to chemotherapy by modulating key signaling pathways. Beyond neoplastic diseases, hyperoside also presents promising therapeutic ...

The Menarini Group, along with its subsidiary Stemline Therapeutics, has announced a partnership with VisualDx to enhance the ...

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive malignancy with fewer than 100 paediatric cases reported. This report details a boy who presented in young childhood with ...

Genmab A/S announced today that the European Commission (EC) has granted marketing authorization for TIVDAK® (tisotumab vedotin), an antibody-drug conjugate (ADC), as monotherapy treatment for adult ...

There was evidence of a smooth periosteal reaction associated with the cranial and caudal cortex of the proximal humerus of ...

gmail.com Objective International guidelines recommend endoscopic surveillance of premalignant gastric lesions. However, the diagnostic yield and preventive effect require further study. We therefore ...

The lesion is heterogeneous of both cystic and solid components ... calcification and eosinophilic hyaline globules suggestive of pseudopapillary pancreatic neoplasm. The case was discussed by a ...

PRODUCTION of gonadotropins is normally restricted to the pituitary and placenta. Tumors containing trophoblastic elements – choriocarcinomas, teratomas and embryonal-cell carcinomas – can ...

The Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc.

Objectives Novel imaging methods based on specific molecular targets to detect both established neoplasms and their precursor lesions are highly desirable in cancer medicine. Previously, we identified ...